<VariationArchive VariationID="16910" VariationName="NM_001395413.1(POR):c.1320dup (p.Ile441fs)" VariationType="Duplication" Accession="VCV000016910" Version="7" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2016-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31949" VariationID="16910">
      <GeneList>
        <Gene Symbol="POR" FullName="cytochrome p450 oxidoreductase" GeneID="5447" HGNC_ID="HGNC:9208" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="75915155" stop="75986855" display_start="75915155" display_stop="75986855" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="75544419" stop="75616172" display_start="75544419" display_stop="75616172" Strand="+" />
          </Location>
          <OMIM>124015</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001395413.1(POR):c.1320dup (p.Ile441fs)</Name>
      <CanonicalSPDI>NC_000007.14:75985132:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="75985132" stop="75985133" display_start="75985132" display_stop="75985133" variantLength="1" positionVCF="75985132" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="75614450" stop="75614451" display_start="75614450" display_stop="75614451" variantLength="1" positionVCF="75614450" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>I441fs</ProteinChange>
      <ProteinChange>I459fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.75614456dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.75614456dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.75985138dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.75985138dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008930.1" sequenceAccession="NG_008930" sequenceVersion="1" change="g.75037dup">
            <Expression>NG_008930.1:g.75037dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367562.3" sequenceAccession="NM_001367562" sequenceVersion="3" change="c.1320dup">
            <Expression>NM_001367562.3:c.1320dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354491.2" sequenceAccession="NP_001354491" sequenceVersion="2" change="p.Ile441fs">
            <Expression>NP_001354491.2:p.Ile441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382655.3" sequenceAccession="NM_001382655" sequenceVersion="3" change="c.1374dup">
            <Expression>NM_001382655.3:c.1374dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369584.2" sequenceAccession="NP_001369584" sequenceVersion="2" change="p.Ile459fs">
            <Expression>NP_001369584.2:p.Ile459fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382657.2" sequenceAccession="NM_001382657" sequenceVersion="2" change="c.1320dup">
            <Expression>NM_001382657.2:c.1320dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369586.2" sequenceAccession="NP_001369586" sequenceVersion="2" change="p.Ile441fs">
            <Expression>NP_001369586.2:p.Ile441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382658.3" sequenceAccession="NM_001382658" sequenceVersion="3" change="c.1320dup">
            <Expression>NM_001382658.3:c.1320dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369587.2" sequenceAccession="NP_001369587" sequenceVersion="2" change="p.Ile441fs">
            <Expression>NP_001369587.2:p.Ile441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382659.3" sequenceAccession="NM_001382659" sequenceVersion="3" change="c.1320dup">
            <Expression>NM_001382659.3:c.1320dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369588.2" sequenceAccession="NP_001369588" sequenceVersion="2" change="p.Ile441fs">
            <Expression>NP_001369588.2:p.Ile441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001395413.1" sequenceAccession="NM_001395413" sequenceVersion="1" change="c.1320dup" MANESelect="true">
            <Expression>NM_001395413.1:c.1320dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001382342.1" sequenceAccession="NP_001382342" sequenceVersion="1" change="p.Ile441fs">
            <Expression>NP_001382342.1:p.Ile441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382662.3" sequenceAccession="NM_001382662" sequenceVersion="3" change="c.1239+180dup">
            <Expression>NM_001382662.3:c.1239+180dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000941.2" sequenceAccession="NM_000941" sequenceVersion="2" change="c.1329dupC">
            <Expression>NM_000941.2:c.1329dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257664" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="124015.0011" DB="OMIM" />
        <XRef Type="rs" ID="786205875" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001395413.1(POR):c.1320dup (p.Ile441fs) AND Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis" Accession="RCV000018410" Version="30">
        <ClassifiedConditionList TraitSetID="5547">
          <ClassifiedCondition DB="MedGen" ID="C3150099">Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001395413.1(POR):c.1320dup (p.Ile441fs) AND not provided" Accession="RCV001008792" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001395413.1(POR):c.1320dup (p.Ile441fs) AND multiple conditions" Accession="RCV002482886" Version="1">
        <ClassifiedConditionList TraitSetID="19524">
          <ClassifiedCondition DB="MedGen" ID="C3150099">Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2936791">Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1860042">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001395413.1(POR):c.1320dup (p.Ile441fs) AND Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" Accession="RCV002513101" Version="2">
        <ClassifiedConditionList TraitSetID="5548">
          <ClassifiedCondition DB="MedGen" ID="C1860042">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-02" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14758361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15264278</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15483095</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20732302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21741353</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22162478</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12699" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ElementValue>
                <XRef ID="MONDO:0013310" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency</ElementValue>
                <XRef ID="Disordered+steroidogenesis+due+to+cytochrome+p450+oxidoreductase+deficiency/8271" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="613571" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ABS1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12664" />
                <XRef ID="12664" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="95699" DB="Orphanet" />
              <XRef ID="C1860042" DB="MedGen" />
              <XRef ID="MONDO:0013310" DB="MONDO" />
              <XRef Type="MIM" ID="613571" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19524" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3367" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis</ElementValue>
                <XRef ID="Antley-Bixler+syndrome+with+genital+anomalies+and+disordered+steroidogenesis/7697" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008726" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POR Deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ABS1</ElementValue>
                <XRef Type="MIM" ID="201750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16665" />
                <XRef ID="16665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="63269" DB="Orphanet" />
              <XRef ID="C3150099" DB="MedGen" />
              <XRef ID="MONDO:0008726" DB="MONDO" />
              <XRef Type="MIM" ID="201750" DB="OMIM" />
            </Trait>
            <Trait ID="12699" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ElementValue>
                <XRef ID="MONDO:0013310" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency</ElementValue>
                <XRef ID="Disordered+steroidogenesis+due+to+cytochrome+p450+oxidoreductase+deficiency/8271" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="613571" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ABS1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12664" />
                <XRef ID="12664" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="95699" DB="Orphanet" />
              <XRef ID="C1860042" DB="MedGen" />
              <XRef ID="MONDO:0013310" DB="MONDO" />
              <XRef Type="MIM" ID="613571" DB="OMIM" />
            </Trait>
            <Trait ID="4596" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis</ElementValue>
                <XRef ID="MONDO:0020667" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trapezoidocephaly synostosis syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multisynostotic osteodysgenesis with long bone fractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteodysgenesis, multisynostotic with fractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Antley-Bixler Syndrome, Autosomal Dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ABS2</ElementValue>
                <XRef ID="GTR000519546" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="207410" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22389" />
                <XRef ID="22389" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="596008" DB="Orphanet" />
              <XRef ID="83" DB="Orphanet" />
              <XRef ID="C2936791" DB="MedGen" />
              <XRef ID="MONDO:0020667" DB="MONDO" />
              <XRef Type="MIM" ID="207410" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5547" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3367" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis</ElementValue>
                <XRef ID="Antley-Bixler+syndrome+with+genital+anomalies+and+disordered+steroidogenesis/7697" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008726" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POR Deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ABS1</ElementValue>
                <XRef Type="MIM" ID="201750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16665" />
                <XRef ID="16665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="63269" DB="Orphanet" />
              <XRef ID="C3150099" DB="MedGen" />
              <XRef ID="MONDO:0008726" DB="MONDO" />
              <XRef Type="MIM" ID="201750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38692" SubmissionDate="2016-10-07" DateLastUpdated="2016-10-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="124015.0011_ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS" title="POR, 1-BP INS, 1329C_ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS" />
        <ClinVarAccession Accession="SCV000038692" DateUpdated="2016-10-10" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Japanese sibs and an unrelated Japanese individual with skeletal findings of Antley-Bixler syndrome and abnormal genitalia and/or impaired steroidogenesis (ABS1; 201750), Fukami et al. (2005) identified compound heterozygosity for mutations in the POR gene, one of which was a 1-bp insertion (1329C) in exon 11, resulting in a truncated protein at codon 449. On the other allele, the 2 sibs had a 1733A-G transition in exon 13, resulting in a tyr578-to-cys substitution (Y578C; 124015.0012); the third patient had an R457H mutation in exon 11 (124015.0005).</Attribute>
              <Citation>
                <ID Source="PubMed">15483095</ID>
              </Citation>
              <XRef DB="OMIM" ID="201750" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POR" />
          </GeneList>
          <Name>POR, 1-BP INS, 1329C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1329C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="124015.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306581" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:708762|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168588" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1329dupC variant in the POR gene, denoted as 1329insC and c.1329_1330insC due to alternative nomenclature, has been reported previously with a second variant in multiple individuals with features of cytochrome P450 oxidoreductase deficiency and Antley-Bixler syndrome (Adachi et al., 2004; Fukami et al, 2005; Ko et al., 2009; Krone et al., 2012). The c.1329dupC variant causes a frameshift starting with codon Isoleucine 444, changes this amino acid to a Histidine residue, and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Ile444HisfsX6. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although not observed as homozygous, the c.1329dupC variant is observed in 5/33494 (0.015%) alleles from individuals of Latio background and 7/234438 (0.003%) total alleles in large population cohorts (Lek et al., 2016). We interpret c.1329dupC as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000941.2:c.1329dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5430880" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000941.2:c.1329dup|OMIM:201750;207410;613571" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002779949" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000941.2:c.1329dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="207410" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613571" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5989248" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="3774224|MedGen:C2673964" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003300553" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14758361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20732302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21741353</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15264278</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15483095</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22162478</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile444Hisfs*6) in the POR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POR are known to be pathogenic (PMID: 14758361, 20732302, 21741353). This variant is present in population databases (rs782496800, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with POR-related conditions (PMID: 15264278, 15483095, 22162478). ClinVar contains an entry for this variant (Variation ID: 16910). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.75614450_75614451insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673964" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5430880" TraitType="Disease" MappingType="XRef" MappingValue="613571" MappingRef="OMIM">
        <MedGen CUI="C1860042" Name="Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38692" TraitType="Disease" MappingType="Name" MappingValue="ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS" MappingRef="Preferred">
        <MedGen CUI="C3150099" Name="Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5430880" TraitType="Disease" MappingType="XRef" MappingValue="207410" MappingRef="OMIM">
        <MedGen CUI="C2936791" Name="Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5430880" TraitType="Disease" MappingType="XRef" MappingValue="201750" MappingRef="OMIM">
        <MedGen CUI="C3150099" Name="Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306581" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5989248" TraitType="Disease" MappingType="XRef" MappingValue="C2673964" MappingRef="MedGen">
        <MedGen CUI="C1860042" Name="Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

